MTOR and cancer: The pathogenesis and progression of cancer involves aberrant regulation of signaling pathways, including MAPK, Wnt/β-catenin, PI3K/AKT/mTOR, STAT3, and NF-κB pathways [82,83,84,85,86,87,88,89].